Based on this medication's long half-life (50 hours), smaller size (396.5 Daltons), and moderate protein binding (71%), it is expected that this medication could enter human milk to some degree. However, due to this medication's massive volume of distribution, it is unlikely much will stay in the plasma compartment of the mother or enter the milk compartment. It is probably compatible for use in a breastfeeding mother. Monitor your baby for: Vomiting, constipation or diarrhea, and urinary retention.
Alicia Nelson RN
Infant Risk Center
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Myrbetriq and breastfeeding a toddler
Collapse
X
Leave a comment: